Vaccination and natural infection both train the immune system, but only one route carries the added risk of long COVID and ...
COVID-19 vaccine resistance has shifted from acute ideological opposition toward broader apathy, a trend now spilling into declining measles vaccination and eroding herd protection. In "COVID-19 ...
Eligibility required diary-confirmed perimenstrual attacks in ≥2 of 3 cycles and excluded chronic migraine and certain aura syndromes, strengthening interpretability for episodic menstrual patterns.
Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs. A retrospective cohort study using the Merative MarketScan ...
AD109 produced statistically significant AHI improvement versus placebo at 26 weeks (treatment difference –4.0 events/hour; ...
Cox-adjusted analyses associated ≥1 year HRT use with reduced all-cause dementia (HR 0.90) and Alzheimer disease (HR 0.84), ...
Large-scale linkage analyses suggest prenatal SARS‑CoV‑2 exposure is not associated with most neurodevelopmental or neurological diagnoses in early childhood. Restricting to pre–March 2022 births ...
Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what ...
Jesse Goodman, MD, MPH, director of the Center on Medical Product Access, Safety and Stewardship (COMPASS) and attending ...
The expert explains 2025-1016 flu, COVID-19, and RSV vaccine updates from AAP, ACOG, AAFP, and IDSA, and what changing schedules mean for pharmacists. Respiratory virus season is underway, and with ...
FDA approved 40-mg and 50-mg BID leniolisib for APDS in children 4–11 years weighing ≥27 kg, representing the first ...
National claims data (>104 million adults) showed higher unadjusted GLP-1 use in SMI, but adjustment for indications and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results